Differential isoform expression of Allergin‐1 during acute and chronic inflammation

Abstract Introduction Neutrophils are crucial to antimicrobial defense, but excessive neutrophilic inflammation elicits immune pathology. Currently, no effective treatment exists to curb neutrophil activation. However, neutrophils express a variety of inhibitory receptors which may represent potenti...

Full description

Bibliographic Details
Main Authors: Ruben J. Geerdink, Maria Inês Pascoal Ramos, Luuk L. van denHoogen, Timothy R. D. J. Radstake, Shiro Shibayama, Akira Shibuya, Louis Bont, Linde Meyaard
Format: Article
Language:English
Published: Wiley 2022-12-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.739
_version_ 1811323025626234880
author Ruben J. Geerdink
Maria Inês Pascoal Ramos
Luuk L. van denHoogen
Timothy R. D. J. Radstake
Shiro Shibayama
Akira Shibuya
Louis Bont
Linde Meyaard
author_facet Ruben J. Geerdink
Maria Inês Pascoal Ramos
Luuk L. van denHoogen
Timothy R. D. J. Radstake
Shiro Shibayama
Akira Shibuya
Louis Bont
Linde Meyaard
author_sort Ruben J. Geerdink
collection DOAJ
description Abstract Introduction Neutrophils are crucial to antimicrobial defense, but excessive neutrophilic inflammation elicits immune pathology. Currently, no effective treatment exists to curb neutrophil activation. However, neutrophils express a variety of inhibitory receptors which may represent potential therapeutic targets to limit neutrophilic inflammation. Indeed, we previously showed that the inhibitory collagen receptor leukocyte‐associated immunoglobulin‐like receptor 1 (LAIR‐1) regulates neutrophilic airway inflammation and inhibits neutrophil extracellular trap formation. The inhibitory receptor Allergin‐1 is expressed by myeloid cells and B cells. Allergin‐1 suppresses mast cell and basophil activation, but a potential regulatory role on neutrophils remains unexplored. We aimed to demonstrate the regulation of neutrophils by Allergin‐1. Methods We examine Allergin‐1 isoform expression on human neutrophils during homeostatic (healthy donors) and chronic inflammatory (systemic lupus erythematosus patients) conditions in comparison to other circulating leukocytes by flow cytometry. To reveal a potential role for Allergin‐1 in regulating neutrophilic inflammation, we experimentally infect wild‐type (WT) and Allergin‐1‐deficient mice with a respiratory syncytial virus (RSV) and monitor disease severity and examine cellular airway infiltrate. Flow cytometry was used to confirm Allergin‐1 expression by airway‐infiltrated neutrophils in RSV infection‐induced bronchiolitis patients. Results Only the short 1 (S1) isoform, but not the long (L) or S2 isoform could be detected on blood leukocytes, with the exception of nonclassical monocytes, which exclusively express the S2 isoform. Allergin‐1 expression levels did not vary significantly between healthy individuals and patients with the systemic inflammatory disease on any interrogated cell type. Airway‐infiltrated neutrophils of pediatric RSV bronchiolitis patients were found to express Allergin‐1S1. However, Allergin‐1‐deficient mice experimentally infected with RSV did not show exacerbated disease or increased neutrophil airway infiltration compared to WT littermates. Conclusion Allergin‐1 isoform expression is unaffected by chronic inflammatory conditions. In stark contrast to fellow inhibitory receptor LAIR‐1, Allergin‐1 does not regulate neutrophilic inflammation in a mouse model of RSV bronchiolitis.
first_indexed 2024-04-13T13:46:43Z
format Article
id doaj.art-6f3d235b6dc740b48e9a6800237a410d
institution Directory Open Access Journal
issn 2050-4527
language English
last_indexed 2024-04-13T13:46:43Z
publishDate 2022-12-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj.art-6f3d235b6dc740b48e9a6800237a410d2022-12-22T02:44:28ZengWileyImmunity, Inflammation and Disease2050-45272022-12-011012n/an/a10.1002/iid3.739Differential isoform expression of Allergin‐1 during acute and chronic inflammationRuben J. Geerdink0Maria Inês Pascoal Ramos1Luuk L. van denHoogen2Timothy R. D. J. Radstake3Shiro Shibayama4Akira Shibuya5Louis Bont6Linde Meyaard7Center for Translational Immunology, University Medical Centre Utrecht Utrecht University Utrecht The NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht Utrecht University Utrecht The NetherlandsDepartment of Rheumatology and Clinical Immunology University Medical Centre Utrecht Utrecht The NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht Utrecht University Utrecht The NetherlandsResearch Centre of Immunology, Tsukuba Institute ONO Pharmaceutical Co., Ltd. Tsukuba Ibaraki JapanDepartment of Immunology, Faculty of Medicine University of Tsukuba Tsukuba Ibaraki JapanCenter for Translational Immunology, University Medical Centre Utrecht Utrecht University Utrecht The NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht Utrecht University Utrecht The NetherlandsAbstract Introduction Neutrophils are crucial to antimicrobial defense, but excessive neutrophilic inflammation elicits immune pathology. Currently, no effective treatment exists to curb neutrophil activation. However, neutrophils express a variety of inhibitory receptors which may represent potential therapeutic targets to limit neutrophilic inflammation. Indeed, we previously showed that the inhibitory collagen receptor leukocyte‐associated immunoglobulin‐like receptor 1 (LAIR‐1) regulates neutrophilic airway inflammation and inhibits neutrophil extracellular trap formation. The inhibitory receptor Allergin‐1 is expressed by myeloid cells and B cells. Allergin‐1 suppresses mast cell and basophil activation, but a potential regulatory role on neutrophils remains unexplored. We aimed to demonstrate the regulation of neutrophils by Allergin‐1. Methods We examine Allergin‐1 isoform expression on human neutrophils during homeostatic (healthy donors) and chronic inflammatory (systemic lupus erythematosus patients) conditions in comparison to other circulating leukocytes by flow cytometry. To reveal a potential role for Allergin‐1 in regulating neutrophilic inflammation, we experimentally infect wild‐type (WT) and Allergin‐1‐deficient mice with a respiratory syncytial virus (RSV) and monitor disease severity and examine cellular airway infiltrate. Flow cytometry was used to confirm Allergin‐1 expression by airway‐infiltrated neutrophils in RSV infection‐induced bronchiolitis patients. Results Only the short 1 (S1) isoform, but not the long (L) or S2 isoform could be detected on blood leukocytes, with the exception of nonclassical monocytes, which exclusively express the S2 isoform. Allergin‐1 expression levels did not vary significantly between healthy individuals and patients with the systemic inflammatory disease on any interrogated cell type. Airway‐infiltrated neutrophils of pediatric RSV bronchiolitis patients were found to express Allergin‐1S1. However, Allergin‐1‐deficient mice experimentally infected with RSV did not show exacerbated disease or increased neutrophil airway infiltration compared to WT littermates. Conclusion Allergin‐1 isoform expression is unaffected by chronic inflammatory conditions. In stark contrast to fellow inhibitory receptor LAIR‐1, Allergin‐1 does not regulate neutrophilic inflammation in a mouse model of RSV bronchiolitis.https://doi.org/10.1002/iid3.739inhibitory receptorneutrophilsnonclassical monocytesrespiratory syncytial virussystemic lupus erythematosus
spellingShingle Ruben J. Geerdink
Maria Inês Pascoal Ramos
Luuk L. van denHoogen
Timothy R. D. J. Radstake
Shiro Shibayama
Akira Shibuya
Louis Bont
Linde Meyaard
Differential isoform expression of Allergin‐1 during acute and chronic inflammation
Immunity, Inflammation and Disease
inhibitory receptor
neutrophils
nonclassical monocytes
respiratory syncytial virus
systemic lupus erythematosus
title Differential isoform expression of Allergin‐1 during acute and chronic inflammation
title_full Differential isoform expression of Allergin‐1 during acute and chronic inflammation
title_fullStr Differential isoform expression of Allergin‐1 during acute and chronic inflammation
title_full_unstemmed Differential isoform expression of Allergin‐1 during acute and chronic inflammation
title_short Differential isoform expression of Allergin‐1 during acute and chronic inflammation
title_sort differential isoform expression of allergin 1 during acute and chronic inflammation
topic inhibitory receptor
neutrophils
nonclassical monocytes
respiratory syncytial virus
systemic lupus erythematosus
url https://doi.org/10.1002/iid3.739
work_keys_str_mv AT rubenjgeerdink differentialisoformexpressionofallergin1duringacuteandchronicinflammation
AT mariainespascoalramos differentialisoformexpressionofallergin1duringacuteandchronicinflammation
AT luuklvandenhoogen differentialisoformexpressionofallergin1duringacuteandchronicinflammation
AT timothyrdjradstake differentialisoformexpressionofallergin1duringacuteandchronicinflammation
AT shiroshibayama differentialisoformexpressionofallergin1duringacuteandchronicinflammation
AT akirashibuya differentialisoformexpressionofallergin1duringacuteandchronicinflammation
AT louisbont differentialisoformexpressionofallergin1duringacuteandchronicinflammation
AT lindemeyaard differentialisoformexpressionofallergin1duringacuteandchronicinflammation